Form 8-K - Current report:
SEC Accession No. 0001829126-25-006735
Filing Date
2025-08-26
Accepted
2025-08-26 16:06:38
Documents
14
Period of Report
2025-08-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novabay_8k.htm   iXBRL 8-K 32830
2 EXHIBIT 99.1 novabay_ex99-1.htm EX-99.1 9351
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5996
  Complete submission text file 0001829126-25-006735.txt   220637

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nby-20250826.xsd EX-101.SCH 2984
5 XBRL LABEL FILE nby-20250826_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE nby-20250826_pre.xml EX-101.PRE 22339
16 EXTRACTED XBRL INSTANCE DOCUMENT novabay_8k_htm.xml XML 3693
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 251257639
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)